INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A transversal challenge. the INVIDIa study

M. Bersanelli, D. Giannarelli, P. Castrignanò, G. Fornarini, S. Panni, F. Mazzoni, M. Tiseo, S. Rossetti, E. Gambale, E. Rossi, A. Papa, A. Cortellini, C. Lolli, R. Ratta, M. Michiara, M. Milella, E.D. Luca, M. Sorarù, C. Mucciarini, F. AtzoriG.L. Banna, L.L. Torre, M.G. Vitale, F. Massari, S.E. Rebuzzi, G. Facchini, G. Schinzari, S. Tomao, S. Bui, V. Vaccaro, G. Procopio, U.D. Giorgi, M. Santoni, C. Ficorella, R. Sabbatini, A. Maestri, C. Natoli, M.D. Tursi, M.D. Maio, E. Rapacchi, A. Pireddu, T. Sava, H. Lipari, F. Comito, E. Verzoni, F. Leonardi, S. Buti

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
Pages (from-to)1229-1239
Number of pages11
JournalImmunotherapy
Volume10
Issue number14
DOIs
Publication statusPublished - 2018

Cite this

Bersanelli, M., Giannarelli, D., Castrignanò, P., Fornarini, G., Panni, S., Mazzoni, F., Tiseo, M., Rossetti, S., Gambale, E., Rossi, E., Papa, A., Cortellini, A., Lolli, C., Ratta, R., Michiara, M., Milella, M., Luca, E. D., Sorarù, M., Mucciarini, C., ... Buti, S. (2018). INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A transversal challenge. the INVIDIa study. Immunotherapy, 10(14), 1229-1239. https://doi.org/10.2217/imt-2018-0080